Market Menagerieexamines technological development and state regulation in the health industries of nations such as India, Brazil, South Africa, Nigeria, and China. It emphasizes the fact that technological advances in the pharmaceutical and life science industries can reinforce economic development and industry growth, but not necessarily positive health outcomes. A vital task for state regulation is, therefore, to reconcile economic and social goals. After all, health policies can be powerful protectionist tools for industrial growth in generics and pricing, for instance, while well-crafted industrial policies can boost health outcomes in drug safety and supply. This book is unique in that it brings together three uncommonly paired themes: the building of industrial capabilities in late industrializers, their politics of health access, and the geography of production and redistribution. This book urges moving beyond market failure to focus on two economic concerns--market varieties and market scales--to integrate the theory and planning of interventions in markets.